Wellnex Life (LSE:WNX) Stock Based Compensation: £0.00 Mil (TTM As of Dec. 2025)


What is Wellnex Life Stock Based Compensation?

Wellnex Life LSE:WNX Stock Based Compensation is £0.00 Mil as of Dec. 2025. The stock has 2 warning signs investors should review.

Wellnex Life's Stock Based Compensation for the six months ended in Dec. 2025 was £0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 was £0.00 Mil.

Wellnex Life Stock Based Compensation Related Terms

Wellnex Life Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for Wellnex Life's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wellnex Life Stock Based Compensation Chart

Wellnex Life Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Wellnex Life Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Wellnex Life Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

What does a Stock Based Compensation of £0.00 Mil mean?
Wellnex Life (LSE:WNX) has a Stock Based Compensation of £0.00 Mil as of Dec. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Wellnex Life and its competitors.
Is Wellnex Life's Stock Based Compensation too high?
Wellnex Life's current Stock Based Compensation is £0.00 Mil.
How does Wellnex Life's Stock Based Compensation compare to KHC and GIS?
Wellnex Life's Stock Based Compensation of £0.00 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Consumer Packaged Goods company?
A good Stock Based Compensation depends on the Consumer Packaged Goods industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for Wellnex Life and its competitors. Wellnex Life's current Stock Based Compensation is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellnex Life stock overvalued right now?
Based on GuruFocus' analysis, Wellnex Life (LSE:WNX) is currently considered Possible Value Trap. The stock's GF Value™ is £0.24, compared to a current price of £0.03 — trading 86.5% below its estimated fair value. The current Stock Based Compensation is £0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For Wellnex Life (LSE:WNX), the current Stock Based Compensation is £0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Wellnex Life Business Description

Other Exchanges 22W0:GermanyWNX:Australia
Address 574 Plummer Street, Building 2, Level 3, Suite 72, Port Melbourne, Melbourne, VIC, AUS, 3207
Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group's offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.